Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data.

Source:http://linkedlifedata.com/resource/pubmed/id/15172407

J. Am. Coll. Cardiol. 2004 Jun 2 43 11 2022-7

Download in:

View as

General Info

PMID
15172407